Literature DB >> 8634638

Women need to be fully informed about risks of hormone replacement therapy.

E H Price, H K Little.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8634638      PMCID： PMC2351052          DOI： 10.1136/bmj.312.7041.1301

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Postmenopausal oestrogen and cardioprotection.

Authors:  J P Vandenbroucke
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

2.  Breast cancer and hormonal supplements in postmenopausal women.

Authors:  K McPherson
Journal:  BMJ       Date:  1995-09-16

3.  Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis.

Authors:  K Hunt; M Vessey; K McPherson
Journal:  Br J Obstet Gynaecol       Date:  1990-12

4.  Utilisation of hormone replacement therapy by women doctors.

Authors:  A J Isaacs; A R Britton; K McPherson
Journal:  BMJ       Date:  1995-11-25
  4 in total
  4 in total

1.  Use of hormone replacement therapy. Evidence on risk of breast cancer associated with hormone replacement therapy is still inconclusive.

Authors:  K Mckinney
Journal:  BMJ       Date:  1996-09-14

2.  Use of hormone replacement therapy. Authors gave distorted view through selective citation.

Authors:  D Ross; M Whitehead; J Stevenson
Journal:  BMJ       Date:  1996-09-14

3.  Use of hormone replacement therapy. May depend on whether the menopause is regarded as physiological or pathological.

Authors:  K Hinshaw
Journal:  BMJ       Date:  1996-09-14

4.  Hormone replacement therapy for all? Long-term randomised controlled trial is needed.

Authors:  R Lyons
Journal:  BMJ       Date:  1996-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.